Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer.
Fukushiro-Lopes DF, Hegel AD, Rao V, Wyatt D, Baker A, Breuer EK, Osipo C, Zartman JJ, Burnette M, Kaja S, Kouzoukas D, Burris S, Jones WK, Gentile S.
Fukushiro-Lopes DF, et al. Among authors: rao v.
Oncotarget. 2017 Dec 4;9(3):3321-3337. doi: 10.18632/oncotarget.22925. eCollection 2018 Jan 9.
Oncotarget. 2017.
PMID: 29423049
Free PMC article.